Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job
Workshop

[Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)


Speakers: Toby Freedman, Synapsis Search Biotech Recruiting; Rachel Kindt, Rachel Kindt Consulting; Sandra Morris, MorTil Consulting; Mandana (Mondee) Baradar, UCB; Joseph Carlino, Carlino Consulting; Anne Wong, Gilead Sciences; Kamana Singh, APS Pharma Solutions; Clare Matti, Network Partners; Ann Lucchesi, LuCore Regulatory Affairs Services; April Nguyen, MMS
Organizers: Toby Freedman, Synapsis Search Biotech Recruiting; Rachel Kindt, Rachel Kindt Consulting; Sandra Morris, MorTil Consulting; Dean Wilson, PBSS
Date: 2024-05-30
Time: 8:30-11:30 Pacific Time
Registration fee: $0
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-05-29  (it will close sooner if the seating cap is reached)

About the Topic

Time (PST) Topic Presenter(s)
8:30-8:50 am PBSS, BPPM, RAPS-SF Welcome and Introduction Shichang Miao (PBSS) Mandana (Mondee) Baradar (BPPM) minKamana Singh (RAPS-SF) 
8:50-9:20 am Career Transition Opportunities: Finding and Following Your Path Toby Freedman, PhD, President, Synapsis Search Biotech Recruiting Rachel Kindt, PhD, Owner, Rachel Kindt Consulting
9:20-9:40 am Project Management: Overview (roles, attributes, paths, lessons learned) Sandra Morris, PhD, Board Member, Consultant, Executive Coach, MorTil Consulting
9:40-9:50 am Panelist presentation Mandana (Mondee) Baradar, MBA, Sr. Program Manager, UCB
9:50-10:00 am Panelist presentation Joseph Carlino, PhD, Principal, Carlino Consulting
10:00-10:10 am Panelist presentation Anne Wong, Associate Director, Global Program Management, Gilead Sciences
10:10-10:30 am Q&A (PM) PM presenters and panelists
10:30-10:40 am Break  
10:40-11:00 am Regulatory Affairs: Overview (roles, attributes, paths, lessons learned) Kamana Singh, MBA, Founder/Executive Consultant, APS Pharma Solutions
11:00-11:10 am Panelist presentation Clare Matti, MS, Sr. Regulatory Affairs Consultant, Network Partners
11:10-11:20 am Panelist presentation Ann Lucchesi, MS, Regulatory Affairs Professional, LuCore Regulatory Affairs Services
11:20-11:30 am Panelist presentation April Nguyen, PharmD, RAC, MPH, Sr. Global Regulatory Affairs Manager, MMS
11:30-11:50 am Q&A (Regulatory) Regulatory presenters and panelists
11:50 am-12:20 pm Panel discussion All presenters and panelists

Other Events of PBSS-San Francisco Bay:

2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies
2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals
2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
©Pharmaceutical & BioScience Society, International; Last Modified: 4/27/2024; Admin Logon
 Ads (in random order)
Submit a Text Ad
($250 for 2 months)
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Lena Biosciences Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
Submit a Text Ad